Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Tilray

<< Previous

Bullboard Posts

Next >>

Comment by Starkickeron Jan 11, 2022 3:23pm

143 Views

Post# 34305101

RE:Tilray

As a shareholder there are legit reasons to be concerned about this company. Their financing was a disaster, they got their butts whipped badly by Valens in the domestic market, Australia isn't living up to expectations, and international revenues are less than a mediocre NHL player's annual salary. 2022 will be a very telling year for this company... if revenue isn't firing on at least two or three cylinders by Q4, it's over.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal